A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Pfizer
Pfizer
Shanghai Junshi Bioscience Co., Ltd.
Eli Lilly and Company
M.D. Anderson Cancer Center
National Cancer Institute (NCI)